SCHEMBL6636685

SCHEMBL6636685

CC(N)CC1CCN(C(=O)[C@](O)(c2ccccc2)C2CCCC2)CC1

nearest known ligand 0.74

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ CHRM3 P20309 20/20 0.74
▸ CHRM2 P08172 6/20 0.74
▸ CHRM1 P11229 6/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27532998 1.00 CHRM3 (0.74) CHRM3CHRM2CHRM1
SCHEMBL6635823 0.86 CHRM3 (1.00) CHRM3CHRM2CHRM1
SCHEMBL6634414 0.85 CHRM2 (0.79) CHRM3CHRM2CHRM1
SCHEMBL28746621 0.85 CHRM2 (0.79) CHRM3CHRM2CHRM1
SCHEMBL6634443 0.85 CHRM3 (0.71) CHRM3CHRM2CHRM1
SCHEMBL27574422 0.85 CHRM3 (0.71) CHRM3CHRM2CHRM1
SCHEMBL16209809 0.84 CHRM3 (0.67) CHRM3CHRM2CHRM1
SCHEMBL6634979 0.83 CHRM3 (1.00) CHRM3CHRM2CHRM1
SCHEMBL27551656 0.83 CHRM3 (1.00) CHRM3CHRM2CHRM1
SCHEMBL12099614 0.82 CHRM3 (0.64) CHRM3CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1290251-A N-acyl cyclic amine derivatives BANYU PHARMA CO LTD (JP) 2001-04-04 — — CN claimed
EP-1061076-B1 N-ACYL CYCLIC AMINE DERIVATIVES BANYU PHARMA CO LTD (JP) 2004-12-08 — — EP disclosed
CN-1290251-A N-acyl cyclic amine derivatives BANYU PHARMA CO LTD (JP) 2001-04-04 — — CN disclosed
EP-1061076-A1 N-ACYL CYCLIC AMINE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2000-12-20 — — EP disclosed
US-6140333-A FOR TREATMENT AND/OR PROPHYLAXIS OF DISEASES INCLUDE SUCH RESPIRATORY DISEASES AS CHRONIC OBSTRUCTIVE PULMONARY DISEASES, CHRONIC BRONCHITIS, ASTHMA, CHRONIC RESPIRATORY OBSTRUCTION, PULMONARY FIBROSIS, PULMONARY EMPHYSEMA BANYU PHARMACEUTICAL CO LTD (JP) 2000-10-31 — — US disclosed
Send feedback